おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Embera NeuroTherapeutics
company
About
Embera NeuroTherapeutics is a development-stage pharmaceutical company developing treatments for smoking cessation and other addictions.
- 11 - 50
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $11M
- Industries
- Biotechnology,Medical Device,Therapeutics
- Founded date
- Jan 1, 2005
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Embera NeuroTherapeutics is a development stage pharmaceutical company focused on developing treatments for smoking cessation and other addictions, for which there are a limited range of effective drug therapies or have no approved treatments. Embera is developing a novel addiction treatment (EMB-001) that targets specific and complementary brain functions that drive the craving and relapse associated with these disorders, an approach based on breakthrough discoveries of the scientific founder.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
6
$18.94M
Embera NeuroTherapeutics has raised a total of
$18.94M
in funding over 2 rounds. Their latest funding was raised on
Dec 19, 2019 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 19, 2019 | Grant | — | 1 |
|
— | Detail |
| Jul 26, 2016 | Grant | $11M | 1 |
National Institutes of Health
|
— | Detail |
| Feb 26, 2015 | Series A | $2.34M | 1 | — | — | Detail |
| Aug 14, 2011 | Series A | $4.50M | 2 | — | — | Detail |
| Sep 15, 2008 | Series Unknown | $300K | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
2
5
Embera NeuroTherapeutics is funded by 5 investors.
Rose Research Center (RRC) in North Carolina
and National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Grant |
|
National Institutes of Health
|
Yes | Grant |
BVM Capital
|
— | Series A |
Louisiana Ventures
|
— | Series A |
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
